Semaglutide in people with obesity: boosts wellbeing and ability to perform daily physical activities

BAGSVÆRD, Denmark, May 13, 2021 /PRNewswire/ -- Novo Nordisk today announced new results from the STEP phase 3a clinical trial programme, demonstrating potential benefits beyond weight loss for people with o...

Full "IntellAsia: Resources" article